Articles by Shimadzu - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Shimadzu

Shimadzu


Articles
Ultra-high Speed HPLC Analysis of USP Methods within the New USP General Chapter 621 Allowed Limits
July 30, 2014

This paper examines the key parameters of allowed HPLC adjustments in the current and revised USP general chapter 621. It then demonstrates the successful transfer to an ultra-high-speed method, reducing analysis time and solvent consumption, and the ability to run on a UHPLC system without changing method parameters.

Ultra Fast UHPLC Method Scouting
September 25, 2013

The traditional process of investigating analytical conditions during method development is often complicated and time-consuming. This Report introduces the Nexera Method Scouting system, a UHPLC system for identifying and resolving the limiting factors associated with traditional method development techniques.

FT-IR Analysis of Dimethicone Based on USP-Specified Method
September 25, 2012

When analyzing viscous solutions by FTIR spectroscopy, the ATR method is particularly effective because the close contact between the sample and prism is easily achieved. This application illustrates an example with the analysis of dimethicone, with good repeatability clearly obtained.

FT-IR Analysis of Dimethicone Based on USP-Specified Method
September 1, 2012

When analyzing viscous solutions by FTIR spectroscopy, the ATR method is particularly effective because the close contact between the sample and prism is easily achieved. This application illustrates an example with the analysis of dimethicone, with good repeatability clearly obtained.

TOC Measurement of Samples Per USP <643>
June 1, 2012

The United States Pharmacopoeia has established guidelines for determining system suitability and established the acceptance of Water For Injection (WFI) purposes and Purified Water (PW) (USP Method <643>). This papers examines the use of Shimadzu’s TOC for meeting these requirements.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here